Dianthus Therapeutics targets severe autoimmune diseases with DNTH103. Read more on DNTH's promise amid competitive ...

The U.S. Food and Drug Administration has approved a self-injection version of Vyvgart Hytrulo (efgartigimod alfa and ...

The newly approved prefilled syringe for self-injection of Vyvgart Hytrulo will provide more convenience and flexibility for ...

After proper training on subcutaneous injection technique, the prefilled syringe may be administered by the patient or caregiver.

FDA approved Vyvgart Hytrulo prefilled syringe for gMG and CIDP self-injection in 20–30 seconds. Human factor studies showed patients and caregivers safely administered the new formulation.

Image: Adobe Stock “As a neuromuscular specialist, a self-injectable treatment option has the potential ... demyelinating polyneuropathy (CIDP)],” Beth Stein, MD, director of neuromuscular ...

It also meant I no longer had to worry about the unknown, all the things I could have, I now knew, I had CIDP. I also experienced a lot of grief of course, and panic about what treatment looked like, ...

The U.S. Food and Drug Administration has approved a prefilled syringe version of Netherlands-based Argenx SE's blockbuster ...

Treatment-emergent adverse events (TEAEs ... Currently, real-world data of 1,316 CIDP patients as of January 31, 2025 treated with VYVGART Hytrulo show that 3.3 per cent of patients reported any ...

“We understand patients experience MG and CIDP in different ways ... Whether patients prefer to receive their treatment in a physician’s office, at home, or while traveling, they can ...

The measure will likely upend the global medicine trade as most countries, the U.S. included, have no or few restrictions on finished drugs, partly because of an agreement struck by the World ...